We are live on ! Find out more
EAM

Erste Asset Management Portfolio holdings

AUM $12.9B
1-Year Est. Return 52.69%
This Fund
S&P 500
This Quarter Est. Return
-4.3%
1 Year Est. Return
+52.69%
3 Year Est. Return
+142.55%
5 Year Est. Return
+182.36%
10 Year Est. Return
AUM
$5.81B
AUM Growth
+$135M
Cap. Flow
+$468M
Cap. Flow %
8.05%
Top 10 Hldgs %
22.38%
Holding
604
New
28
Increased
196
Reduced
108
Closed
52

Top Buys

Rank Stock Value
1
V icon
Visa
V
+$52.7M
2
MDGL icon
Madrigal Pharmaceuticals
MDGL
+$45.1M
3
PCAR icon
PACCAR
PCAR
+$42.3M
4
KLAC icon
KLA
KLAC
+$37.4M
5
AMZN icon
Amazon
AMZN
+$23.1M

Top Sells

Rank Stock Value
1
MAR icon
Marriott International
MAR
+$51.7M
2
ABT icon
Abbott
ABT
+$30.9M
3
PFE icon
Pfizer
PFE
+$29.6M
4
VSAT icon
Viasat
VSAT
+$18M
5
QCOM icon
Qualcomm
QCOM
+$14.8M

Sector Composition

Rank Sector Weight
1 Technology 31.85%
2 Healthcare 18.76%
3 Financials 9.65%
4 Consumer Discretionary 9.57%
5 Industrials 9.31%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
PCRX icon
451
Pacira BioSciences
PCRX
$1,000M
$302K 0.01%
9,800
BCRX icon
452
BioCryst Pharmaceuticals
BCRX
$2.39B
$290K 0.01%
40,000
ABCL icon
453
AbCellera Biologics
ABCL
$1.96B
$289K 0.01%
62,000
SWTX
454
DELISTED
SpringWorks Therapeutics
SWTX
$289K 0.01%
12,300
RPM icon
455
RPM International
RPM
$14.8B
$287K ﹤0.01%
+3,000
New +$292K
BCYC
456
Bicycle Therapeutics
BCYC
$277M
$283K ﹤0.01%
14,000
PICK icon
457
iShares MSCI Global Metals & Mining Producers ETF
PICK
$2.32B
$273K ﹤0.01%
6,850
MRVI icon
458
Maravai LifeSciences
MRVI
$920M
$273K ﹤0.01%
28,400
BAC icon
459
Bank of America
BAC
$440B
$265K ﹤0.01%
9,691
-310,895
-97% -$9.2M
VIR icon
460
Vir Biotechnology
VIR
$1.5B
$265K ﹤0.01%
28,800
LGND icon
461
Ligand Pharmaceuticals
LGND
$6.34B
$264K ﹤0.01%
4,300
RXRX icon
462
Recursion Pharmaceuticals
RXRX
$1.7B
$260K ﹤0.01%
33,500
HYG icon
463
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
$16.6B
$260K ﹤0.01%
3,530
+800
+29% +$59.7K
GRFS
464
Grifois
GRFS
$5.32B
$250K ﹤0.01%
27,056
MPT
465
Medical Properties Trust
MPT
$2.79B
$239K ﹤0.01%
45,700
CRVL icon
466
CorVel
CRVL
$3.11B
$239K ﹤0.01%
3,600
CINF icon
467
Cincinnati Financial
CINF
$27.2B
$239K ﹤0.01%
2,300
RGNX icon
468
Regenxbio
RGNX
$712M
$230K ﹤0.01%
13,000
RDN icon
469
Radian Group
RDN
$4.83B
$223K ﹤0.01%
8,800
CHGG icon
470
Chegg
CHGG
$95.9M
$213K ﹤0.01%
23,808
BNY
471
Bank of New York Mellon
BNY
$108B
$206K ﹤0.01%
4,841
-340
-7% -$15.1K
WELL icon
472
Welltower
WELL
$169B
$205K ﹤0.01%
2,500
-800
-24% -$65.8K
GLW icon
473
Corning
GLW
$139B
$198K ﹤0.01%
6,514
ADPT icon
474
Adaptive Biotechnologies
ADPT
$3.78B
$198K ﹤0.01%
35,700
REPL icon
475
Replimune Group
REPL
$1.03B
$196K ﹤0.01%
11,900

Similar funds

Erste Asset Management's Q3 2023 Portfolio in Review

As of Q3 2023, Erste Asset Management held 604 positions worth $5.81B, up 2.4% from $5.67B the previous quarter. Its ten largest holdings account for 22% of the portfolio.

Erste Asset Management deployed $468M of net new capital in Q3 2023, opening 28 new positions and adding to 196 existing holdings. Its largest new stake was Constellation Brands: 50,120 shares worth $12.6M.

By sector, the portfolio is most concentrated in Technology at 32% of assets, down from 32% a quarter earlier, followed by Healthcare and Financials.

On the sell side, the largest reduction was Marriott International, an estimated $51.7M trimmed.

  • Erste Asset Management's largest Q3 2023 buy was Constellation Brands: 50,120 shares worth $12.6M.
  • Erste Asset Management added most to Visa in Q3 2023, an estimated $52.7M increase.
  • Erste Asset Management's biggest Q3 2023 reduction was Marriott International, cutting an estimated $51.7M.
  • Erste Asset Management fully exited Viasat in Q3 2023, selling an estimated $18M.
  • Erste Asset Management's ten largest holdings make up 22% of its $5.81B portfolio in Q3 2023.
  • Erste Asset Management opened 28 new positions and closed 52 in Q3 2023.
  • Erste Asset Management's portfolio value rose 2.4% quarter-over-quarter to $5.81B.

Based on Erste Asset Management's 13F filing for Q3 2023, filed 26 Nov 2024.